Cargando…

The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020

Cancer is one of the important health problems in Iran, which is considered as the third cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most common endocrine tumors, includes about one percent of malignant cancer. In this study, we examined the 15-year national tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Balajam, Narges Zargar, Mousavian, Amir-Hossein, Sheidaei, Ali, Gohari, Kimiya, Tavangar, Seyed Mohammad, Ghanbari-Motlagh, Ali, Ostovar, Afshin, Shafiee, Gita, Heshmat, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172312/
https://www.ncbi.nlm.nih.gov/pubmed/37164997
http://dx.doi.org/10.1038/s41598-023-34155-2
_version_ 1785039596355059712
author Balajam, Narges Zargar
Mousavian, Amir-Hossein
Sheidaei, Ali
Gohari, Kimiya
Tavangar, Seyed Mohammad
Ghanbari-Motlagh, Ali
Ostovar, Afshin
Shafiee, Gita
Heshmat, Ramin
author_facet Balajam, Narges Zargar
Mousavian, Amir-Hossein
Sheidaei, Ali
Gohari, Kimiya
Tavangar, Seyed Mohammad
Ghanbari-Motlagh, Ali
Ostovar, Afshin
Shafiee, Gita
Heshmat, Ramin
author_sort Balajam, Narges Zargar
collection PubMed
description Cancer is one of the important health problems in Iran, which is considered as the third cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most common endocrine tumors, includes about one percent of malignant cancer. In this study, we examined the 15-year national trend of endocrine cancer incidence in Iranian men and women. The data in each province were evaluated based on age, gender, and cancer type according to International Classification of Disease Codes version 10 (ICD-10) from 2005 to 2020 in Iran. All data were obtained from the reports of the Statistics Center of Iran (SCI), 6 phases of the step-by-step approach to monitoring the risk factors of chronic diseases over 18 years old (STEPs), and 3 periods of the CASPIAN study (survey of non-communicable diseases in childhood and adolescence). Statistical analyzes and graph generation were done using R statistical software. Poisson regression with mixed effects was used for data modeling and incidence rate estimation. The incidence of thyroid gland malignancy is higher in women than in men. On the other hand, the incidence of adrenal gland cancer is slightly higher in men than in women. The same pattern is observed for other endocrine neoplasms and related structures. The incidence rate of these types of cancers has generally increased from 2005 to 2020 in Iran. This increase is more in women than in men. In addition, in the middle of the country, there is a strong region in terms of the occurrence of these types of cancers. The incidence rate in these provinces is relatively higher for both sexes and all studied periods. We conducted a study to observe the changing trends for various types of endocrine cancers over 15 years in men and women. Considering the increasing trend of thyroid cancers in Iran, therefore, creating essential policies for the management of these types of cancers for prevention, rapid diagnosis, and, timely treatment is particularly important.
format Online
Article
Text
id pubmed-10172312
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101723122023-05-12 The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 Balajam, Narges Zargar Mousavian, Amir-Hossein Sheidaei, Ali Gohari, Kimiya Tavangar, Seyed Mohammad Ghanbari-Motlagh, Ali Ostovar, Afshin Shafiee, Gita Heshmat, Ramin Sci Rep Article Cancer is one of the important health problems in Iran, which is considered as the third cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most common endocrine tumors, includes about one percent of malignant cancer. In this study, we examined the 15-year national trend of endocrine cancer incidence in Iranian men and women. The data in each province were evaluated based on age, gender, and cancer type according to International Classification of Disease Codes version 10 (ICD-10) from 2005 to 2020 in Iran. All data were obtained from the reports of the Statistics Center of Iran (SCI), 6 phases of the step-by-step approach to monitoring the risk factors of chronic diseases over 18 years old (STEPs), and 3 periods of the CASPIAN study (survey of non-communicable diseases in childhood and adolescence). Statistical analyzes and graph generation were done using R statistical software. Poisson regression with mixed effects was used for data modeling and incidence rate estimation. The incidence of thyroid gland malignancy is higher in women than in men. On the other hand, the incidence of adrenal gland cancer is slightly higher in men than in women. The same pattern is observed for other endocrine neoplasms and related structures. The incidence rate of these types of cancers has generally increased from 2005 to 2020 in Iran. This increase is more in women than in men. In addition, in the middle of the country, there is a strong region in terms of the occurrence of these types of cancers. The incidence rate in these provinces is relatively higher for both sexes and all studied periods. We conducted a study to observe the changing trends for various types of endocrine cancers over 15 years in men and women. Considering the increasing trend of thyroid cancers in Iran, therefore, creating essential policies for the management of these types of cancers for prevention, rapid diagnosis, and, timely treatment is particularly important. Nature Publishing Group UK 2023-05-10 /pmc/articles/PMC10172312/ /pubmed/37164997 http://dx.doi.org/10.1038/s41598-023-34155-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Balajam, Narges Zargar
Mousavian, Amir-Hossein
Sheidaei, Ali
Gohari, Kimiya
Tavangar, Seyed Mohammad
Ghanbari-Motlagh, Ali
Ostovar, Afshin
Shafiee, Gita
Heshmat, Ramin
The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
title The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
title_full The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
title_fullStr The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
title_full_unstemmed The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
title_short The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
title_sort 15-year national trends of endocrine cancers incidence among iranian men and women; 2005–2020
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172312/
https://www.ncbi.nlm.nih.gov/pubmed/37164997
http://dx.doi.org/10.1038/s41598-023-34155-2
work_keys_str_mv AT balajamnargeszargar the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT mousavianamirhossein the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT sheidaeiali the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT goharikimiya the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT tavangarseyedmohammad the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT ghanbarimotlaghali the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT ostovarafshin the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT shafieegita the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT heshmatramin the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT balajamnargeszargar 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT mousavianamirhossein 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT sheidaeiali 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT goharikimiya 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT tavangarseyedmohammad 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT ghanbarimotlaghali 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT ostovarafshin 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT shafieegita 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020
AT heshmatramin 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020